NCT05306405 is a Phase 1, PHASE2 clinical trial of Vaginal Tablet in Cervix; Pregnancy, sponsored by Ain Shams University.

Who is sponsoring NCT05306405?

NCT05306405 is sponsored by Ain Shams University.

What drugs are being tested in NCT05306405?

Interventions in NCT05306405: Vaginal Tablet.

What condition does NCT05306405 study?

NCT05306405 studies Cervix; Pregnancy.

Is NCT05306405 still recruiting?

NCT05306405 is currently status unknown. Last updated 1 April 2022.

Last reviewed 2022-04-01 · How we verify

NCT05306405

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream

Status unknown Phase 1, PHASE2 Last updated 1 April 2022

What this trial tests

Phase 1, PHASE2 trial testing Vaginal Tablet in Cervix; Pregnancy in 120 participants. Status unknown.

Timeline

20 February 2022

Primary endpoint
1 August 2022

30 August 2022

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 1, PHASE2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	120
Start date	20 February 2022
Primary completion	1 August 2022
Estimated completion	30 August 2022
Sites	1 location across Egypt

Drugs / interventions tested

Vaginal Tablet

Conditions studied

Cervix; Pregnancy — all drugs for Cervix; Pregnancy →

Sponsor

Ain Shams University

Who can join

Adults 20 to 39, female only, with Cervix; Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the safety and effectiveness of vaginal misoprostol with combined vaginal misoprostol and estradiol for induction of labour in unfavorable cervix

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cervix; Pregnancy

Currently open trials in the same condition.

NCT05246579 — Prospective Evaluation of Pathways for Preterm Birth · recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05306405 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 1 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05306405.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing